Martin M. Schumacher
Sissach, BL, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Reconsidering the Association Between Epilepsy and Schizophrenia: Diagnostic Misclassification of Epilepsy-related Psychoses.
Journal: The Journal of nervous and mental disease
Published: December 08, 2025
Re-rethinking psychosis: Time to retire "functional", "explanatory" and "primary".
Journal: Schizophrenia research
Published: October 08, 2025
Schizophrenia and schizoaffective are useful terms of essential concepts in medicine: what we need is a general consideration and more research regarding the causes of secondary psychotic syndromes.
Journal: European archives of psychiatry and clinical neuroscience
Published: May 30, 2025
Editorial: Mental illness and neuropsychiatry of the homeless: psychosis, personality, drug abuse, and other brain disorders.
Journal: Frontiers in psychology
Published: June 12, 2024
Cortisol and the Dexamethasone Suppression Test as a Biomarker for Melancholic Depression: A Narrative Review.
Journal: Journal of personalized medicine
Published: April 14, 2023
Evidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis.
Journal: Experimental dermatology
Published: March 25, 2015
Gene expression profiling of immunomagnetically separated cells directly from stabilized whole blood for multicenter clinical trials.
Journal: Clinical and translational medicine
Published: January 01, 2014
Robust and tissue-independent gender-specific transcript biomarkers.
Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
Published: July 09, 2013
Increased survival despite failure of transplanted human hepatocyte implantation into liver parenchyma of nude mice with repeated lethal Jo2-induced liver deficiency.
Journal: Cell transplantation
Published: May 03, 2013
Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial.
Journal: Annals of the rheumatic diseases
Published: January 31, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026